Company news
Renerve Limited (ASX:RNV) news
Renerve Limited news releases on 6ix. Latest, Oct 5, 2026: ReNerve AGM Presentation
Press releases & updates
ReNerve AGM Presentation
October 4, 2026
ReNerve completes first cases in Hong Kong and Malaysia
September 20, 2026
ReNerve and RMIT awarded $499k grant
September 6, 2026
ReNerve Secures Marketing Approval in India
August 9, 2026
ReNerve Secures Marketing Approval in the Philippines
August 5, 2026
Q4 FY26 Activities Report and Appendix 4C
July 28, 2026
ReNerve Secures up to A$5 Million Funding Facility
July 8, 2026
ReNerve Secures Marketing Approval in Indonesia
July 5, 2026
ReNerve appoints J4 as second Empliq manufacturing partner
June 10, 2026
ReNerve appoints distribution partner for Malaysian Market
June 4, 2026
New distribution agreement for broader Hong Kong market
May 31, 2026
Quarterly Investor Presentation
May 8, 2026
Q3 FY26 Activities Report and Appendix 4C
April 30, 2026
Nerve Guide Matrix Enters Stage 3 of Commercial Development
April 15, 2026
1HFY26 Results Announcement
February 26, 2026
1HFY26 Appendix 4D and Half Year Report
February 26, 2026
Q2 FY26 Activities Report and Appendix 4C
January 29, 2026
ReNerve receives approval in Malaysia
January 14, 2026
Broader approval received in Hong Kong for Nerve Cuff
January 11, 2026
ReNerve AGM Presentation
November 26, 2025
ReNerve completes $3.2m capital raising
November 19, 2025
Trading Halt
November 17, 2025
Nerve Cuff approved for use in US DoD and VA hospitals
November 12, 2025
ReNerve Clinical Study Expansion
November 4, 2025
Q1 FY26 Activities Report and Appendix 4C
October 22, 2025
ReNerve achieves first sales of amniotic tissue range
October 13, 2025
Investor Roadshow Presentation
September 28, 2025
Empliq Product Launch
September 22, 2025
ReNerve launches the EmpliQ product ranges
September 22, 2025
ReNerve - Appendix 4E
August 28, 2025
ReNerve records first sale of deep dermal product range
August 17, 2025
Q4 FY25 Activities Report and Appendix 4C
July 30, 2025
Expands Product Portfolio with Berkley partnership / Webinar
June 1, 2025
ReNerve receives market approval in Bahrain
May 28, 2025
ReNerve - Q3 FY25 Activities Report & Appendix 4C
April 29, 2025
Expands Global Footprint with Strategic Partnership in India
April 9, 2025
Response to ASX Aware Letter
March 31, 2025
Clinical Outcome Demonstrates Material Benefits for Patients
March 27, 2025
1HFY25 Results Announcement
February 27, 2025
1HFY25 Appendix 4D and Half Year Report
February 27, 2025
ReNerve - Q2 FY25 Activities Report & Appendix 4C
January 28, 2025
Exclusive Partnership with Supplier in the Middle East
December 9, 2024
Exclusive Partnership with Leading Distributor in Hong Kong
December 2, 2024